論文(2021)

著書

1　髙橋浩一郎、グッドパスチャー症候群：今日の治療指針2021；874-876：医学書院、2021年

2 中村朝美、荒金尚子：肺癌の外来管理；呼吸器疾患最新の治療 2021-2022、422-424、南江堂

3　嬉野博志，木村晋也：慢性白血病の診断と治療：慢性骨髄性白血病（CML）・慢性リンパ性白血病（CLL）．ライフライン21がんの先進医療特集：血液のがん－診断と治療，Vol．42，18‐22．蕗書房，神奈川 2021，7．

4　勝屋弘雄：成人Ｔ細胞白血病・リンパ腫（ATL）の診断と治療．ライフライン21がんの先進医療特集：血液のがん－診断と治療，Vol．42，27‐31．蕗書房，神奈川 2021，7．

原著論文

1 Sueoka-Aragane N, Nakashima C, Yoshida H, Matsumoto N, Iwanaga K, Ebi N, Nishiyama A, Yatera K, Kuyama S, Fukuda M, Ushijima S, Umeguchi H, Harada D, Kashiwabara K, Suetsugu T, Fujimoto N, Tanaka F, Uramoto H, Yoshii C, Nakatomi K, Koh G, Seki N, Aoe K, Nosaki K, Inoue K, Takamori A, Kawaguchi A. The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment. Cancer Med. 2021 Jun;10(12):3873-3885. doi: 10.1002/cam4.3929.

2 Sadamatsu H, Takahashi K, Tashiro H, Kusaba K, Haraguchi T, Kurihara Y, Komiya N, Nakashima C, Nakamura T, Kimura S, Sueoka-Aragane N. A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Mycobacterium avium Complex Pulmonary Disease. J Clin Med. 2021;10(8):1576. doi: 10.3390/jcm10081576.

3 Tashiro H, Takahashi K, Tanaka M, Sadamatsu H, Kurihara Y, Tajiri R, Takamori A, Naotsuka H, Imaizumi H, Kimura S, Sueoka-Aragane N. Skeletal muscle is associated with exercise tolerance evaluated by cardiopulmonary exercise testing in Japanese patients with chronic obstructive pulmonary disease. Sci Rep. 2021;11(1):15862. doi: 10.1038/s41598-021-95413-9.

4 Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease. Takahashi K, Tashiro H, Tajiri R, Takamori A, Uchida M, Kato G, Kurihara Y, Sadamatsu H, Kinoshita T, Yoshida M, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group. Int J Chron Obstruct Pulmon Dis. 2021 Dec 6;16:3297-3307.

5 Effect of health locus of control on physical activity in stable patients with chronic obstructive pulmonary diseases. Egoshi S, Hayashi S, Horie J, Shiranita S, Watanabe H, Kawaura F, Takahashi K, Asami T, Sueoka-Aragane N. J Phys Ther Sci. 2021 Jun;33(6):480-488.

6 Validation of Clinical Characteristics and Effectiveness of Pulmonary Rehabilitation in a COPD Population with Discrepancy between Exercise Tolerance and FEV1. Horie J, Takahashi K, Shiranita S, Anami K, Hayashi S. Healthcare (Basel). 2021 Jan 6;9(1):53.

7 Matsumoto A, Nakashima C, Kimura S, Sueoka E, Aragane N. ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies. BMC Cancer. 2021 May 22;21(1):584.

8 呼吸器内科医師の海外留学に関するアンケート調査．小林信明, 髙橋浩一郎, 浅井一久, 礒部威, 今泉和良, 大平徹郎, 長内忍, 川山智隆, 國近尚美, 小林和幸, 佐野博幸, 多賀谷悦子, 千葉弘文, 橋本直純, 須田隆文, 金子猛,日本呼吸器学会将来計画委員会, 日本呼吸器学会誌 10(2): 102-107, 2021.

9 日本呼吸器学会会員における大学院進学に関する最近の動向．髙橋浩一郎, 小林信明, 浅井一久, 礒部威, 今泉和良, 大平徹郎, 長内忍, 川山智隆, 國近尚美, 小林和幸, 佐野博幸, 多賀谷悦子, 千葉弘文, 橋本直純, 須田隆文, 金子猛,日本呼吸器学会将来計画委員会, 日本呼吸器学会誌 10(3): 207-211, 2021.

10　Ureshino H, Shindo T, Tanaka H, Saji H, Kimura S.　HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia　Mol Cancer Ther, 20: 142-149 2021・1

11　Takahashi K, Sadamatsu H, Suzuki K, Tashiro H, Kimura S, Kuratomi Y, Sueoka-Aragane N　Evaluation of olfactory dysfunction to estimate the presence of eosinophilic chronic rhinosinusitis in patients with asthma Respiratory Investigation,　59: 126-134　2021・1

12　Egoshi S, Hayashi S, Horie J, Shiranita S, Watanabe H, Kawaura F, Takahashi K, Asami T, Sueoka-Aragane N　Effect of health locus of control on physical activity in stable patients with chronic obstructive pulmonary diseases Journal of Physical Therapy Science 33(6):480-488　2021・6

13　Nakamura N, Maruyama D, Machida R, Ichinohe T, Takayama N, Ohba R, Ohmachi K, Imaizumi Y, Tokunaga M, Katsuya H, Yoshida I, Sunami K, Kurosawa M, Kubota N, Morimoto H, Kobayashi M, Kato H, Kameoka Y, Kagami Y, Kizaki M, Takeuchi K, Munakata W, Iida S, Nagai H.　Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)　Jpn J Clin Oncol. 51(7):1059-1066.　2021・7

14　Ureshino H, Kurahashi Y, Watanabe T, Yamashita S, Kamachi K, Yamamoto Y, Fukuda-Kurahashi Y, Yoshida N, Hattori N, Hayashi Y, Kawaguchi A, Tohyama K, Okada S, Harada H, Ushijima T, Kimura S　Silylation of deoxynucleotide analog yields an orally available drug with anti-leukemia effects Mol Cancer Ther, 20: 1412-1421　2021・8

15　Kimura S, Hosoya K, Ogata K, Furuno T, Sogawa R, Takeuchi K, Tasaki M, Kawaguchi A, Nishioka A, Sueoka-Aragane N, Noshiro H, Kuratomi Y, Yokoyama M, Noguchi M, Anzai K, Yamashita Y, Kimura S, Irie H Severity of constipation related to palonosetron during first-line chemotherapy: A retrospective observational study　Support Care Cancer, 29:4723-4732　2021・8

16　Tashiro H, Takahashi K, Tanaka M, Sadamatsu H, Kurihara Y, Tajiri R, Takamori A, Naotsuka H, Imaizumi H, Kimura S, Sueoka-Aragane N　Skeletal muscle is associated with exercise tolerance evaluated by cardiopulmonary exercise testing in Japanese patients with chronic obstructive pulmonary disease　scientific reports 11(1):15862　2021・8

17　Itamura H, Shindo T, Muranushi H, Kitaura K, Okada S, Shin-I T, Suzuki R, Takaori-Kondo A, Kimura S　Pharmacological MEK inhibition promotes polyclonal T-cell reconstitution and suppresses xenogeneic GVHD　Cell Immunol, 367:104410-104414　2021・9

18　Hoshiko T, Kubota Y, Onodera R, Higashi T, Yokoo M, Motoyama K, Kimura S　Folic acid-appended hydroxypropyl-β-cyclodextrin exhibits potent antitumor activity in chronic myeloid leukemia cells via autophagic cell death.　Cancers, 13: 5413-5429　2021・10

19　Tomogane M, Sano Y, Shimizu D, Shimizu T, Miyashita M, Toda Y, Hosogi S, Tanaka Y, Kimura S, Ashihara E Human Vγ9Vδ2 T cells exert anti-tumor activity independently of PD-L1 expression in tumor cells Biochem Biophys Res Commun, 573: 132-139　2021・10

20　Ureshino H, Kamachi K, Nishioka A, Okamoto S, Katsuya H, Yoshimura M, Kubota Y, Ando T, Kimura S　Subsequent attempts at tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience Hematol Oncol, 39: 549-557　2021・10

21　Tan BJ, Sugata K, Reda O, Matsuo M, Uchiyama K, Miyazato P, Hahaut V, Yamagishi M, Uchimaru K, Suzuki Y, Ueno T, Suzushima H, Katsuya H, Tokunaga M, Uchiyama Y, Nakamura H, Sueoka E, Utsunomiya A, Ono M, Satou Y.　HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia/lymphoma　J Clin Invest. 131:e150472.　2021・11

22　Murai K, Ureshino H, Kumagai T, Tanaka H, Nishiwaki K, Wakita S, Inokuchi K, Fukushima T, Yoshida C, Uoshima N, Kiguchi T, Mita M, Aoki J, Kimura S, Karimata K, Usuki K, Shimono J, Chinen Y, Kuroda J, Matsuda Y, Nakao K, Ono T, Fujimaki K, Shibayama H, Mizumoto C, Takeoka T, Io K, Kondo T, Miura M, Minami Y, Ikezoe T, Imagawa J, Takamori A, Kawaguchi A, Sakamoto J, Kimura S　Low-dose dasatinib in older chronic myeloid leukaemia patients (DAVLEC study): a single-arm, multicentre, phase 2 trial.　Lancet Haematol, 8: e902-e911　2021・12

23　Takahashi K, Tashior H, Tajiri Ｒ, Takamori Ａ, Uchida Ｍ, Kato Ｇ, Kurihara Y, Sadamatsu H, Kinoshita T, Yoshida M, Atsushi K, Kimura S, Sueoka-Aragane N, Kawayama T　Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease Int J COPD, 16: 3298-3307　2021・12

24　Katsuya H, Cook LBM, Rowan AG, Melamed A, Turpin J, Ito J, Islam S, Miyazato P, Jek Yang Tan B, Matsuo M, Miyakawa T, Nakata H, Matsushita S, Taylor GP, Bangham CRM, Kimura S, Satou Y.　Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals　J Infect Dis. 225:317-326 2022・1

25　Tashiro H, Takahashi K, Kurihara Y, Sadamatsu H, Kuwahara Y, Kimura S, Sueoka-Aragane N.　Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series. 　J Asthma Allergy 15:169-177　2022・1

26　Kataoka H, Saita T, Sogawa R, Yamamoto Y, Matsui S, Kimura S, Kimura S, Shin M　Development of a competitive enzyme-linked immunosorbent assay for the determination of sunitinib unaffected by light-induced isomerization　Biol Pharm Bull, 44: 1565-1570　2021

27 ＊Hyeok-Jae Jang, Young-Min Woo, Kazuhito Naka, Jong-Ho Park, Ho-Jae Han, Hee-Jin Kim, Sun-Hee Kim, Jae-Sook Ahn, Taehyung Kim, Shinya Kimura, Sarah Zarabi, Jeffrey H Lipton, Mark D Minden, Chul-Won Jung, Hyeoung-Joon Kim, Jong-Won Kim, Dennis Dong Hwan Kim: Statins Enhance the ―2― Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors. Cancers (Basel), 13(21): 5543, 2021, 11.

総説

1　"Kobayashi T, Ureshino H, Morimoto T, Shimanoe C, Ikuta K, Sonohata M, Mawatari M.

"Treatment strategy for upper cervical epidural abscess: a literature review.　Nagoya J Med Sci. 2021 Feb;83(1):1-20　2021, 2

2　Tashiro H, Shore SA　The Gut Microbiome and Ozone-induced Airway Hyperresponsiveness. Mechanisms and Therapeutic Prospects American　Journal of Respiratory Cell and Molecular Biology　2021・3

3　嬉野博志, 木村晋也無治療寛解維持(TFR)の考え方とTKI中止の可能性; 血液内科, 82, 3, 314 – 320　2021年3月

4　Ureshino H　Treatment free remission and immunity in chronic myeloid leukemia　Int J Hematol. 2021, 113:642-647　2021, 5

5　木村早希子、末岡榮三朗、木村晋也　術前中止薬管理アプリの開発と臨床応用　日本血栓止血学会誌、32(3)：339-348,　2021・6

6　木村晋也　骨髄系疾患―慢性骨髄性白血病　臨床血液, 62(6); 572-581　2021・7

7　嬉野博志、木村晋也慢性白血病の診断と治療 : 慢性骨髄性白血病(CML)・慢性リンパ性白血病(CLL) ライフライン21がんの先進医療特集:血液のがん : 診断と治療, 42, 27-31　2021年7月

8　勝屋弘雄、木村晋也　成人T細胞白血病・リンパ腫（ATL）の診断と治療ライフライン21がんの先進医療特集:血液のがん : 診断と治療, 42, 27-31 2021年7月

9　木村晋也　急性白血病と骨髄異形成症候群に対する分子標的治療　医学の歩み, 278(13):1　2021・9

10　岡本翔、木村晋也　フィラデルフィア染色体陽性急性リンパ性白血病の分子標的治療　医学の歩み. 278(13):1113-1119, 2021　2021・9

11　嬉野博志　慢性骨髄性白血病の無治療寛解維持におけるKIR/HLAアレル多型　月刊細胞, 特集:細胞の個性と競合, Topics from special edition, 53, 10, 619-623　2021年9月

12　江頭彩, 松本美樹, 木村晋也　高額療養費制度　内科, 128(4): 915-919　2021・10

13　Kobayashi T, Ureshino H, Morimoto T, Sonohata M, Mawatari M　Pain relief differentiated according to the length of time that preoperative skin traction was carried out for hip fractures: A systematic review and meta-analysis　"J Orthop Trauma Nurs　uma Nurs..2021 Nov;43:100886."　2021.11.

14　嬉野博志　CMLと免疫　日本臨床79(11), 1776-1781　2021年11月

15　嬉野博志　慢性骨髄性白血病の無治療寛解維持におけるKIR/HLAアレル多型　アグリバイオ　2021年12月

症例報告

1 Tashiro H, Takahashi K, Haraguchi T, Jinnouchi K, Kimura S, Sueoka-Aragane N. A 45-Year-Old Man With Acute Chest Pain, Fever, and Dyspnea After Tooth Extraction. Chest. 2021 Dec;160(6):e623-e628. doi: 10.1016/j.chest.2021.07.049.

2 Komiya N, Takahashi K, Kato G, Kubota M, Tashiro H, Nakashima C, Nakamura T, Iwanaga K, Kimura S, Sueoka-Aragane N. Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer. Case Rep Oncol. 2021 Mar 29;14(1):599-603. doi: 10.1159/000514146.

3 Haraguchi T, Tashiro H, Takahashi K, Kurihara Y, Sadamatsu H, Miyahara N, Hiratsuka M, Kimura S, Sueoka-Aragane N. Idiopathic eosinophilic pleurisy: A practical diagnostic approach. Respir Med Case Rep. 2021 May 20;33:101430.

4 Kurihara Y, Tashiro H, Takahashi K, Komiya N, Sadamatsu H, Kimura S, Sueoka-Aragane N. Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan. Intern Med. 2021 Apr 15;60(8):1251-1255.

5 Tashiro H, Takahashi K, Kurihara Y, Sadamatsu H, Kimura S, Sueoka-Aragane N. Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis. Allergol Int. 2021 Jan;70(1):145-147.

6　栗原有紀、田代宏樹、髙橋浩一郎、中島千穂、中村朝美、副島英伸、荒金尚子　Birt-Hogg-Dubé症候群、1家系内2 例の臨床的特徴日本内科学会雑誌　110巻2号、274-281　2021・2

7　Kidoguchi K, Kubota Y, Nishimura Y, Kizuka-Sano H, Kimura S　 Ibrutinib-induced cardiac tamponade in chronic lymphocytic leukemia　Turk J Hematol, 38: 83-85 2021・2

8　Kidoguchi K, Kubota Y, Fujimoto S, Sakata Y, Kizuka-Sano H, Yamaguchi K, Ureshino H, Katsuya H, Ando T, Esaki M, Kimura S　Aplastic anemia in a patient with Cronkhite-Canada syndrome　 Int Med, 60: 1601-1605　2021・5

9　Umino A, Kubota Y, Honda-Yoshigai M, Okazaki T, Yoshihara Y, Wakayama K, Kawasaki S, Kusaba K, Kimura S. Sueoka E　Monitoring of tumor cells by flow cytometry permits rapid evaluation of disease progression in monomorphic epitheliotropic intestinal T-cell　Cytometry: Part B - Clinical Cytometry, 100: 454-456 20217・7

10　Kitamura H, Kubota Y, Tomimasu R, Ide R, Yoshida M, Tsuruda S, Kimura S, Miyahara M　Development of acquired hemophilia A after treatment of bronchial asthma with benralizumab　Indian J Hematol Blo, 37:509-510　2021.7

11　Kidoguchi K, Ureshino H, Kizuka-Sano H, Yamaguchi K, Katsuya H, Kubota Y, Ando T, Miura M, Takahashi N, Kimura S　Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A case series from a single institute Int J Hematol, 114: 199-204　2021・8

12　Ureshino H, Ohshima K, Miyahara M　MultiplemyelomawithG-CSFproductionmimickingchronicneutrophilicleukemia ejHaem, 2: 299-300　2021.8

13　Fujita M, Ureshino H, Sugihara A, Nishioka A, Kimura S Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young Woman Cureus, 13: e17942-e17945　2021・9

14　Kawano N, Kimura S, Miura M, Tochigi T, Nakaike T, Yamashita K, Mashiba K, Kikuchi I, Takahashi N　The serial examinations of the pharmacokinetics of ponatinib in cases with CML and Ph+ALL　Int J Hematol, 114: 509-516　2021・10

15　Fujita M, Ureshino H, Kimura S　Helicobacter cinaedi bacteremia in a patient with primary central nervous system lymphoma　eJHaem;2:875–876.　2021.11

16　Tashiro H, Takahashi K, Haraguchi T, Jinnouchi K, Kimura S, Sueoka-Aragane N　A 45-year-old man with acute chest pain, fever, and dyspnea after tooth extraction　CHEST, 160: e623-e628　2021・12

17　彌富瑞貴, 中園貴彦, 江頭玲子, 山口　健, 中島千穂, 甲斐敬太, 入江裕之　肺MALT リンパ腫からびまん性大細胞型B 細胞リンパ腫への形質転換における画像的変化を観察できた1 例　臨床放射線67：49-54　2022・1

最終更新日　2022年10月5日

2021年

(C)佐賀大学医学部附属病院血液・呼吸器・腫瘍内科